Troleandomycin

From WikiMD's Wellness Encyclopedia

(Redirected from Treolmicina)

troleandomycin

Troleandomycin is a macrolide antibiotic that is derived from oleandomycin. It is used primarily in the treatment of bacterial infections and is known for its effectiveness against certain types of bacteria.

Chemical Structure and Properties[edit | edit source]

Troleandomycin is a semi-synthetic derivative of oleandomycin. It is chemically modified to enhance its pharmacokinetic properties. The chemical structure of troleandomycin includes a macrolide ring, which is a large lactone ring with attached deoxy sugars.

Mechanism of Action[edit | edit source]

Troleandomycin works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, thereby preventing the translocation of peptides. This action effectively halts the growth and replication of the bacteria.

Clinical Uses[edit | edit source]

Troleandomycin is used to treat a variety of bacterial infections, particularly those caused by Gram-positive bacteria. It is often prescribed for respiratory tract infections, skin infections, and other conditions where macrolide antibiotics are indicated.

Pharmacokinetics[edit | edit source]

Troleandomycin is administered orally and is well-absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the bile. The drug has a relatively long half-life, which allows for less frequent dosing compared to some other antibiotics.

Side Effects[edit | edit source]

Common side effects of troleandomycin include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. In some cases, it may cause hepatotoxicity, which necessitates monitoring of liver function during treatment.

Drug Interactions[edit | edit source]

Troleandomycin can interact with other medications metabolized by the liver, particularly those that are substrates of the cytochrome P450 enzyme system. These interactions can lead to increased levels of the co-administered drugs and a higher risk of adverse effects.

History and Development[edit | edit source]

Troleandomycin was developed as a semi-synthetic derivative to improve upon the properties of oleandomycin. It was introduced into clinical practice in the mid-20th century and has since been used in various therapeutic contexts.

Related Pages[edit | edit source]

Categories[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD